Solventum price target raised to $75 from $71 at Piper Sandler

Piper Sandler raised the firm’s price target on Solventum (SOLV) to $75 from $71 and keeps a Neutral rating on the shares following Q3 results. The early execution from the Solventum team is solid, and the firm is also getting a flavor of how this management team approaches setting guidance, Piper told investors in a research note.